105 related articles for article (PubMed ID: 27982417)
61. New drug approvals in acute myeloid leukemia: what's the best end point?
Estey E; Othus M; Lee SJ; Appelbaum FR; Gale RP
Leukemia; 2016 Mar; 30(3):521-5. PubMed ID: 26677969
[No Abstract] [Full Text] [Related]
62. T315I mutation with lymphoblasts in a newly diagnosed patient with chronic-phase chronic myeloid leukemia.
Kimura K; Tsukamoto S; Takaishi K; Isshiki Y; Kayamori K; Hino Y; Ohshima-Hasegawa N; Mitsukawa S; Takeda Y; Mimura N; Takeuchi M; Ohwada C; Iseki T; Nakaseko C; Sakaida E
Leuk Lymphoma; 2019 Jun; 60(6):1591-1594. PubMed ID: 31161870
[No Abstract] [Full Text] [Related]
63. Dominant-negative Ikaros cooperates with BCR-ABL1 to induce human acute myeloid leukemia in xenografts.
Theocharides AP; Dobson SM; Laurenti E; Notta F; Voisin V; Cheng PY; Yuan JS; Guidos CJ; Minden MD; Mullighan CG; Torlakovic E; Dick JE
Leukemia; 2015 Jan; 29(1):177-87. PubMed ID: 24791856
[TBL] [Abstract][Full Text] [Related]
64. The diagnostic profile of rare acute myelomegakaryoblastic leukemia.
Xu DM; Yu WJ; Xie L; Zhang ZW; Qiu JF; Xu CW; He CL; Xu XR; Xu JS; Li Q; Yin J
Leuk Lymphoma; 2021 Dec; 62(13):3204-3211. PubMed ID: 34477034
[TBL] [Abstract][Full Text] [Related]
65. Acute myeloid leukemia with mutated NPM1 demonstrating multilineage dysplasia and marked thrombocytosis.
Chen Y; Pourabdollah M; Chang H
Br J Haematol; 2017 Aug; 178(3):350. PubMed ID: 28677819
[No Abstract] [Full Text] [Related]
66. The role of bone marrow morphology in the diagnosis of relapsed acute myeloid leukemia.
Said B; Gilles S; Weisdorf D; Rashidi A
Leukemia; 2018 Apr; 32(4):1053. PubMed ID: 29091604
[No Abstract] [Full Text] [Related]
67. PCM1-JAK2 Fusion in a Patient With Acute Myeloid Leukemia.
Lee JM; Lee J; Han E; Kim M; Kim Y; Han K; Kim HJ
Ann Lab Med; 2018 Sep; 38(5):492-494. PubMed ID: 29797824
[No Abstract] [Full Text] [Related]
68. A new case of CD7-positive acute myeloblastic leukemia with trisomy 21 as a sole acquired abnormality.
Yamamoto K; Nagata K; Hamaguchi H
Cancer Genet Cytogenet; 2002 Mar; 133(2):183-4. PubMed ID: 11943351
[No Abstract] [Full Text] [Related]
69.
Sadigh S; Morrissette JJD; Bagg A
Leuk Lymphoma; 2019 Jun; 60(6):1601-1602. PubMed ID: 30632836
[No Abstract] [Full Text] [Related]
70.
Neuendorff NR; Hemmati P; Arnold R; Ihlow J; Dörken B; Müller-Tidow C; Westermann J
Blood Adv; 2018 Jun; 2(12):1409-1411. PubMed ID: 29914972
[No Abstract] [Full Text] [Related]
71.
Wang L; Yang M; Zhang X; Yang C; Huang X; Wang Z; Jin J
Haematologica; 2017 Nov; 102(11):e470-e472. PubMed ID: 28751556
[No Abstract] [Full Text] [Related]
72. Romboutsia-induced bone marrow necrosis at presentation of acute myeloid leukaemia.
Seviar D; Nyunt K; Sayer C; Wright D; Rider T
Br J Haematol; 2022 Jan; 196(2):262. PubMed ID: 34581439
[No Abstract] [Full Text] [Related]
73. The other Achilles' heel of BCR-ABL1.
De Keersmaecker K
Haematologica; 2012 Jan; 97(1):2. PubMed ID: 22210326
[No Abstract] [Full Text] [Related]
74. The FAB classification for acute myeloid leukaemia--is it outdated?
Segeren CM; van 't Veer MB
Neth J Med; 1996 Sep; 49(3):126-31. PubMed ID: 8854677
[No Abstract] [Full Text] [Related]
75. Auer rods in neutrophils in bone marrow and peripheral blood in mixed phenotype acute leukaemia in a child.
Kabbage S; Cupaiolo R; Rozen L; Demulder A
Br J Haematol; 2019 Mar; 184(5):708. PubMed ID: 30407611
[No Abstract] [Full Text] [Related]
76. New opportunities and new problems for acute myeloid leukemia treatment.
Lahortiga I; Cools J
Haematologica; 2012 Jun; 97(6):796. PubMed ID: 22665527
[No Abstract] [Full Text] [Related]
77. Lysosomal acid lipase deficiency diagnosed in a patient presenting with acute myeloid leukaemia.
Hsu H; Roncolato F; Lee SH
Br J Haematol; 2021 Jul; 194(2):228. PubMed ID: 33694176
[No Abstract] [Full Text] [Related]
78. BCR::ABL1 fusion gene positive de novo acute myeloid leukemia with coexistence of NRAS mutation and presented with a peculiar CD58 positive immunophenotype.
Zhang X; Guo X
Cytometry B Clin Cytom; 2024 Mar; 106(2):146-148. PubMed ID: 37969054
[No Abstract] [Full Text] [Related]
79. Triphenotypic acute leukaemia: the contribution of multimodality laboratory diagnostic techniques.
Leitinger E; Kuzich JA; Juneja S
Pathology; 2021 Aug; 53(5):678-680. PubMed ID: 33461800
[No Abstract] [Full Text] [Related]
80. Improving prediction accuracy in acute myeloid leukaemia: micro-environment, immune and metabolic models.
Hu F; Wang Y; Wang WD; Gale RP; Wu BY; Liang Y
Leukemia; 2021 Nov; 35(11):3073-3077. PubMed ID: 34365474
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
